7Baggers
Quarterly
Annual
    Unit: USD2019-03-31 2018-03-31 2017-03-31 2016-03-31 2015-03-31 2014-03-31 
      
          
      cash flows from operating activities:
          
      net income
    43,314,000 33,148,000 25,541,000 23,344,000 25,646,000 17,083,000 
      adjustments to reconcile net income to net cash from operating activities:
          
      depreciation and amortization
    4,449,000 3,922,000 4,141,000 4,588,000   
      amortization of intangible assets
    799,000 1,006,000 1,121,000 1,214,000 1,093,000 1,235,000 
      benefit from credit losses -
          
      deferred income tax expense
    13,900,000 5,472,000  3,635,000 2,060,000  
      stock-based compensation
    1,018,000 2,205,000 1,734,000 1,557,000 1,457,000 717,000 
      unrealized gain on derivative instruments
          
      net (gain) loss on disposals or sales of premises and equipment and other assets
          
      net gain on sales of loans
    -1,536,000 -1,096,000 -1,472,000 -2,488,000 -1,689,000 -2,017,000 
      net amortization/accretion of premiums, discounts, and deferred loan fees and costs
    -2,023,000 -2,095,000 -2,031,000    
      originations and purchases of loans held for sale
    -74,225,000 -65,984,000 -81,389,000 -107,034,000 -89,425,000 -72,748,000 
      sales and repayments of loans held for sale
    78,654,000 76,163,000 86,924,000 108,615,000 87,051,000 72,865,000 
      amortization of broker placement fees
    189,000 367,000 527,000 858,000 1,335,000 1,785,000 
      net amortization of premiums and discounts on investment securities
          
      increase in accrued interest receivable
    -669,000      
      increase in other assets
        3,081,000  
      increase in other liabilities
    -7,053,000 166,000 8,517,000 -11,167,000 11,007,000 -4,987,000 
      cash flows from investing activities:
          
      net (disbursements) repayments on loans held for investment
          
      proceeds from sales of loans held for investment
    4,998,000 13,274,000 53,245,000  2,230,000 16,558,000 
      proceeds from sales of repossessed assets
    11,250,000 10,559,000 12,159,000 12,375,000 18,446,000 12,262,000 
      purchases of available-for-sale debt securities
          
      proceeds from principal repayments and maturities of available-for-sale debt securities
          
      purchases of held-to-maturity debt securities
          
      proceeds from principal repayments and maturities of held-to-maturity debt securities
          
      additions to premises and equipment
    -4,046,000 -5,142,000 -2,840,000 -3,006,000 -3,027,000 -7,696,000 
      proceeds from sales of premises and equipment and other assets
          
      net purchases of other investment securities
          
      payment related to previous acquisition
          
      cash flows from financing activities:
          
      net increase in deposits
    84,436,000 45,026,000 58,722,000 95,879,000 -166,924,000 120,977,000 
      repayments of long-term borrowings
          
      repurchase of outstanding common stock
    -1,882,000 -2,624,000 -528,000 -259,000 -236,000 -246,000 
      dividends paid on common stock
    -6,538,000      
      dividends paid on preferred stock
    -669,000 -669,000 -669,000    
      net increase in cash and cash equivalents
    3,372,000 127,429,000 124,437,000 274,367,000 188,328,000 185,826,000 
      cash and cash equivalents at beginning of period
    586,203,000 716,395,000 299,685,000 752,458,000 796,108,000 655,671,000 
      cash and cash equivalents at end of period
    589,575,000 843,824,000 424,122,000 1,026,825,000 984,436,000 841,497,000 
      cash and cash equivalents include:
          
      cash and due from banks
    581,838,000 743,409,000 414,034,000 813,732,000 767,471,000 824,547,000 
      the accompanying notes are an integral part of these financial statements.
          
      benefit from loan and lease losses
    11,820,000 20,544,000 25,442,000 21,053,000 32,970,000 31,915,000 
      gain on early extinguishment of debt
     -2,316,000  -4,217,000   
      otti on debt securities
          
      net gain on sales of premises and equipment and other assets
    -17,000      
      net amortization/accretion of premiums, discounts and deferred loan fees and costs
       -2,343,000 -673,000  
      net amortization/accretion of premium and discounts on investment securities
     476,000 461,000 447,000 1,269,000  
      decrease in accrued interest receivable
     13,061,000 3,413,000 3,806,000 1,953,000  
      increase in accrued interest payable
    736,000 8,000 174,000 2,257,000 1,000,000 2,106,000 
      decrease (increase) in other assets
          
      net cash from operating activities
    82,982,000 95,376,000 84,803,000 54,277,000 75,513,000 73,508,000 
      principal collected on loans
    642,758,000 590,753,000 669,615,000 735,801,000 751,062,000 776,086,000 
      loans originated and purchased
    -817,900,000 -550,257,000 -704,175,000 -627,105,000 -705,621,000 -774,764,000 
      purchases of available-for-sale securities
     -49,626,000 -5,003,000    
      proceeds from principal repayments and maturities of available-for-sale securities
    57,809,000 100,195,000 53,830,000    
      proceeds from principal repayments of held-to-maturity securities
    142,000 141,000     
      proceeds from sale of premises and equipment and other assets
    18,000 1,857,000 637,000  2,492,000 25,000 
      net redemptions/purchase of other investment securities
          
      proceeds from the settlement of insurance claims
          
      net cash from investing activities
    -104,871,000 111,754,000 82,109,000 131,495,000 279,975,000 -8,360,000 
      repayment of securities sold under agreements to repurchase
          
      net fhlb advances repayments
          
      repayment of junior subordinated debentures
     -21,434,000  -7,025,000   
      net cash from financing activities
    25,261,000 -79,701,000 -42,475,000 88,595,000 -167,160,000 120,678,000 
      money market instruments
    7,737,000 100,415,000 10,088,000 213,093,000 216,965,000 16,950,000 
      the accompanying notes are an integral part of these statements.
          
      unrealized (gain) loss on derivative instruments
          
      loans held for sale valuation adjustments
          
      decrease in other assets
    14,176,000 10,566,000 5,419,000 3,320,000  8,657,000 
      change in securities sold under agreements to repurchase
    -50,086,000 -100,000,000     
      unrealized loss on derivative instruments
    -589,000 52,000 57,000 153,000   
      loans held for sale valuation adjustment
     558,000     
      net amortization/accretion of premiums and discounts on investment securities
    39,000      
      net redemptions/purchases of other investment securities
    100,000      
      deferred income tax (benefit) expense
      -6,016,000   -700,000 
      gain on sale of investments
          
      gain from recovery of investments previously written off
          
      gain from insurance proceeds
          
      decrease (increase) in accrued interest receivable
         4,992,000 
      proceeds from sales of available-for-sale securities
       14,990,000   
      proceeds from recovery of investments previously written off
          
      net redemptions/purchases of other investments securities
          
      proceeds from settlement of insurance claims
          
      net cash outflows from purchase/sale of insurance contracts
          
      net fhlb advances proceeds
          
      cash and cash equivalents at beginning of year
          
      cash and cash equivalents at end of year
          
      net fhlb advances (repayments) proceeds
          
      other-than-temporary impairments on debt securities
      12,231,000 6,687,000 156,000  
      net (gain) loss on sales of premises and equipment and other assets
     -847,000     
      net redemptions of other equity securities
          
      net fhlb advances paid
      -100,000,000    
      gain on sales of investments
          
      bargain purchase gain
        -13,443,000  
      gain on sale of merchant contracts
          
      impairment of fixed assets
          
      increase increase in accrued interest payable
          
      purchases of held-to-maturity investment securities
          
      proceeds from principal repayments and maturities of held-to-maturity securities
      141,000    
      proceeds from sale of merchant contracts
          
      net purchases/sales of other equity securities
          
      net cash received from acquisition
        217,659,000  
      net purchase/sales of other equity securities
          
      net decrease in deposits
          
      loss on sales of premises and equipment and other assets
      9,000    
      net redemptions (purchases) of other equity securities
      4,500,000    
      purchase of insurance contracts
       -1,067,000   
      equity in loss of unconsolidated entity
         6,610,000 
      gain on sales of premises and equipment and other assets
          
      gain on extinguishment of debt
          
      proceeds from principal repayments and maturities of securities held to maturity
          
      net (purchases) redemptions/sales of other equity securities
          
      repayments of junior subordinated debentures
          
      issuance costs of common stock issued in exchange for preferred stock
          
      series a through e
          
      net decrease in cash and cash equivalents
          
      net gain on disposition of premises and equipment and other assets
          
      purchases of securities held to maturity
          
      repayment of fhlb advances
          
      purchase of securities held to maturity
          
      purchases of other equity securities
       -141,000 -433,000  
      purchases of securities available for sale
       -62,770,000 -56,429,000 -76,253,000 
      proceeds from principal repayments and maturities of securities available for sale
       62,418,000 53,596,000 45,422,000 
      other-than-temporary impairments on equity securities
          
      impairment of collateral pledged to lehman
          
      depreciation
        5,306,000 5,453,000 
      deferred income tax benefit
          
      (gain) loss on sales of premises and equipment and other assets
          
      repurchases of outstanding common stock
          
      issuance costs of common stock issued in exchange for preferred stock series a through e
         -53,000 
      increase in accrued income tax payable
        5,481,000 1,476,000 
      net purchases of other equity securities
          
      derivative instruments and financial liabilities measured at fair value, unrealized loss
        72,000  
      gain on sale of premises and equipment and other assets
        -194,000 -25,000 
      derivative instruments and financial liabilities measured at fair value,
          
      unrealized gain
          
      net redemptions/sales (purchases) of other equity securities
          
      net repayments of securities sold under agreements to repurchase
          
      repayments of medium-term notes
          
      proceeds from common stock sold, net of costs
          
      derivative instruments and financial liabilities measured at fair value, gain
         -148,000 
      net amortization of premiums, discounts and deferred loan fees and costs
         -477,000 
      net amortization of premium and discounts on investment securities
         -284,000 
      net redemptions/sales of other equity securities
          
      proceeds from sale of premises and equipments and other assets
          
      loss on early extinguishment of borrowings
          
      derivative instruments and financial liabilities measured at fair value, (gain) loss
          
      (gain) loss on sale of premises and equipment and other assets
          
      net amortization of premiums, discounts, and deferred loan fees and costs
          
      proceeds from sales of held-to-maturity securities
          
      proceeds from sales of premises and equipments and other assets
          
      proceeds from securities litigation settlement and other proceeds
          
      net repayments and cancellation costs of securities sold under agreements to repurchase
          
      net fhlb advances (paid) proceeds and cancellation costs
          
      dividends paid
          
      amortization and impairment of intangible assets
          
      proceeds from sale of loans held for investment
          
      proceeds from sale of repossessed assets
          
      net fhlb advances (paid) proceeds
          
      proceeds from common stock sold
          
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.